EARLI
Live / Registered — Registered (as of 14 Mar 2023)
What this means for you
Registered since 14 Mar 2023. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 88020634
- Registration number
- 7000700
- Mark type
- Stylized text
- Filed
- 29 Jun 2018
- Published for opposition
- 14 Jan 2020
- Registered
- 14 Mar 2023
- Attorney of record
- Connie L. Ellerbach
Goods and services
- Class 001 — Chemicals: Assays, recombinant nucleic acid vectors, transfection agents, reagents, enzymes, and nucleotides for clinical or medical laboratory, scientific, or research purposes; diagnostic or screening assays or agents, reagents, enzymes, and nucleotides for clinical or medical laboratory, scientific, and research, purposes; reagents for medical and genetic research; chemical reagents and diagnostic preparations for clinical or medical laboratory use
- Class 005 — Pharmaceuticals: Pharmaceutical and veterinary preparations and products for the prevention, detection, localization, and treatment of cancer, respiratory diseases, and liver diseases; Drug delivery agents in the form of compounds that facilitate the delivery of other pharmaceutical products into human and animal bodies; clinical medical diagnostic or therapeutic reagents and clinical diagnostic kits comprised of clinical medical diagnostic or therapeutic reagents; medical diagnostic or therapeutic reagents and medical diagnostic or therapeutic kits comprised of medical diagnostic or therapeutic reagents; reagents for medical use and medical diagnostics or therapeutics and screening kits comprised of reagents for medical diagnostics and screening use or therapeutics; reagents for use in testing for medical and medical diagnostic purposes; diagnostic and therapeutic preparations for medical purposes, namely, to detect and treat cancer, respiratory diseases, and liver diseases; diagnostic or therapeutic assays, vectors, reagents, enzymes, and nucleotides for medical or clinical purposes; diagnostic or screening assays, reagents, enzymes, and nucleotides for medical diagnostic purposes and treatment purposes, namely, to detect and treat cancer, respiratory diseases, and liver diseases; reagents for medical diagnostic purposes and treatment use; therapeutic agents for medical diagnostic purposes and treatment, namely, viral vectors and non-viral transfection agents based on linear or branched polyethylenimines, nanoparticles, lipophilic particles, peptides, micelles, dendrimers, hydrogels, synthetic or naturally derived exosomes, polymeric composition, or virus-like particles, which facilitate the delivery of pharmaceuticals or nucleic acids into human and animal bodies to detect and treat cancer, respiratory diseases, and liver diseases
Owner
- Earli Inc., Mountain View, CA, US
- Earli Inc., Mountain View, CA, US
- Earli Inc., Mountain View, CA, US
Prosecution history
- 14 Mar 2023 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 14 Mar 2023 — REGISTERED-PRINCIPAL REGISTER
- 10 Feb 2023 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 09 Feb 2023 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 02 Feb 2023 — STATEMENT OF USE PROCESSING COMPLETE
- 31 Jan 2023 — USE AMENDMENT FILED
- 31 Jan 2023 — TEAS STATEMENT OF USE RECEIVED
- 18 Jan 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 17 Jan 2023 — SOU EXTENSION 5 GRANTED
- 15 Dec 2022 — SOU EXTENSION 5 FILED
- 04 Jan 2023 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 15 Dec 2022 — SOU TEAS EXTENSION RECEIVED
- 16 Jun 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 14 Jun 2022 — SOU EXTENSION 4 GRANTED
- 14 Jun 2022 — SOU EXTENSION 4 FILED